Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC

Multiple Myeloma or Lymphoma: Study of CLR 131 in Relapsed or Refractory Select B-Cell Malignancies

Research Question:
Is the study drug, CLR 131, effective for the treatment of multiple myeloma or certain lymphomas?

Basic Study Information

This research is being done to help us determine if the study drug is safe and can be tolerated for the treatment of multiple myeloma or certain lymphomas.

Location: Cancer Center
Study Web URL:
Study Reference #: IMMY17015

Lead Researcher (Principal Investigator)

Lead Researcher:  Brea Lipe

Study Contact Information

Study Coordinator: Andrew Bui
Phone: (585) 276-4405

Additional Study Details

Learn More About These Conditions

More information about Lymphoma

More information about Multiple Myeloma

Return to Search